Literature DB >> 31488391

NICE guidance on dapagliflozin with insulin for type 1 diabetes.

Amanda I Adler1, Sharlene Ting2, Ross Dent2, Nick Latimer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31488391     DOI： 10.1016/S2213-8587(19)30265-7

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  3 in total

Review 1.  Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering.

Authors:  Brendon L Neuen; David Z Cherney; Meg J Jardine; Vlado Perkovic
Journal:  CMAJ       Date:  2019-10-15       Impact factor: 8.262

Review 2.  Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 1 Diabetes Mellitus.

Authors:  Ning Li; Ruimin Chen; Kewei Liu
Journal:  Clin Drug Investig       Date:  2020-11       Impact factor: 2.859

3.  Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium-Glucose Cotransporter 2 Inhibitor.

Authors:  Rhea Teng; Martin Kurian; Kelly L Close; John B Buse; Anne L Peters; Charles M Alexander
Journal:  Diabetes Spectr       Date:  2021-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.